Securities code: Blue Sail Medical Co.Ltd(002382) securities abbreviation: Blue Sail Medical Co.Ltd(002382) Announcement No.: 2022025 bond Code: 128108 bond abbreviation: lanfan convertible bond
Blue Sail Medical Co.Ltd(002382)
Announcement on holding 2021 online performance briefing
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Blue Sail Medical Co.Ltd(002382) (hereinafter referred to as “the company”) will hold the 2020 annual performance presentation on panorama.com from 15:00 to 17:00 p.m. on Wednesday, May 6, 2022. This presentation will be held remotely. Investors can log in to the “investor relations interactive platform”（ http://ir.p5w.net. ）Participate in this briefing. The company’s personnel attending this briefing are: Ms. Liu Wenjing, chairman of the board, Mr. Zhong Shuqiao, director, President and Secretary of the board of directors, Mr. Gong bengao, independent director, Mr. Cui Yuntao, general manager of the financial management center, and Ms. Bai Xuelian, head of the financial department.
In order to fully respect investors and improve the pertinence of exchanges, the company now solicits questions from investors in advance for this performance description meeting, and widely listens to investors’ opinions and suggestions. Investors can send relevant questions to email before May 6, 2022: [email protected]. , the company will answer the questions generally concerned by investors at the online performance briefing.
The board of directors and management of the company sincerely thank the majority of investors for their attention and support to the company, and welcome investors to actively participate in this performance briefing!
It is hereby announced.
Blue Sail Medical Co.Ltd(002382)
Board of directors
April 13, 2002
